AN INTERDISCIPLINARY STUDY OF DELAYED SLEEP PHASE DISORDER

描述(申请人提供)：昼夜节律睡眠障碍占失眠诊断病例的15%，其中延迟睡眠相障碍(DSPD)占此类病例的绝大多数。这些睡眠相障碍的诊断和治疗受到严重缺乏解决障碍关键方面的数据的阻碍，包括几乎没有充分描述睡眠障碍本身的研究。DSPD的病理生理学基础在很大程度上仍然是理论上的，这也是由于缺乏关于这个问题的数据。识别昼夜节律睡眠障碍的遗传标记的进展，结合已建立的研究人类睡眠和生物节律的方法，为昼夜节律睡眠障碍的研究提供了令人兴奋的途径。这项研究的目的是使用跨学科的方法来加强我们对这种障碍的理解，以及对正常睡眠调节的理解。我们将测试以下假设：1)被诊断为DSPD的个体将表现出1)显著长于正常对照组的自发周期长度(Tau)；2)导致睡眠质量下降的睡眠和体温之间的相位关系改变；3)一个或多个标准时钟基因的变异以及tau分子的异常。最后，我们假设，在两组(DSPD和正常对照组)中，tau的行为(睡眠/清醒、活动记录)和生理(体温、褪黑素)测量将与tau的分子测量呈正相关。40名受试者(20名被诊断为DSPD，20名正常对照)将接受一项实验室方案，该方案由牵引性和“自由运行”部分组成，在此期间，睡眠和昼夜节律变量被连续记录。在来自成纤维细胞的细胞培养中，将通过使用RT-PCR技术跟踪时钟基因的节律表达，并通过分析生物钟驱动的荧光素酶报告的表达来测量分子tau。分析将集中在DSPD和正常对照组之间tau的假设差异，DSPD的睡眠特征，睡眠质量与昼夜相角之间的关系的检查，以及在行为、生理和分子水平上评估的昼夜指标之间的假设关系的检查。这项工作将是第一次使用这种跨学科的方法在行为和生理水平上更好地描述和理解正常和病理性的昼夜睡眠调节，同时获得对人类睡眠/醒来系统昼夜节律背后的遗传学的重要见解。

DESCRIPTION (provided by applicant): Circadian rhythm sleep disorders constitute up to 15% of diagnosed cases of insomnia, with Delayed Sleep Phase Disorder (DSPD) representing a large majority of such cases. Diagnosis and treatment of these sleep phase disturbances are hampered by a remarkable paucity of data addressing key aspects of the disorders, including a virtual absence of studies that adequately characterize the sleep disturbance, itself. The pathophysiology underlying DSPD remains largely theoretical in scope, due also to a lack of data shedding light on this issue. Advances in the identification of genetic markers for circadian rhythm sleep disorders, combined with established methods for studying human sleep and biological rhythms, offer exciting avenues in the study of circadian rhythm sleep disorders. The aim of this study is to use an interdisciplinary approach to enhance our understanding of such disorders, and that of normal sleep regulation. We will test the hypotheses that individuals diagnosed with DSPD will exhibit 1) spontaneous period lengths (tau) that are significantly longer than normal controls; 2) altered phase relationships between sleep and body temperature that contribute to reduced sleep quality; 3) variations in one or more of the canonical clock genes as well as aberrant molecular tau. Finally, we hypothesize that across both groups (DSPD and normal controls), behavioral (sleep/wake, actigraphy) and physiological (body temperature, melatonin) measurements of tau will be positively correlated with molecular measurements of tau. Forty subjects (20 diagnosed with DSPD, 20 normal controls) will undergo a laboratory protocol consisting of entrained and "free-run" components, during which sleep and circadian variables are continuously recorded. 'Molecular' tau will be measured in cell cultures derived from fibroblasts, by tracking rhythmic expression of clock loci using RT-PCR techniques, and by analyzing the expression of a circadian clock-driven luciferase reporter. Analyses will focus on hypothesized differences in tau between DSPD, and normal controls, on the characterization of sleep in DSPD, on examination of the relationships between sleep quality and circadian phase-angle, and on the examination of hypothesized relationships among circadian measures assessed at the behavioral, physiologic and molecular levels. This work will be the first to use such an interdisciplinary approach to better characterize and understand normal and pathological circadian sleep regulation at the behavioral and physiological levels, while gaining important insights into the genetics that underlie circadian timing of the human sleep/wake system.